OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ERAS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Erasca (ERAS) Earnings Date & Reports

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ERAS is expected to report earnings to fall 11.67% to -10 cents per share on November 05

Q3'25

Est.

$-0.11

Q2'25

Est.

$-0.12

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.06

The last earnings report on August 12 showed earnings per share of -11 cents, meeting the estimate of -11 cents. With 148.67K shares outstanding, the current market capitalization sits at 453.87M.

View a ticker or compare two or three

Compare

ERAS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ERAS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ERAS showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3115 Merryfield Row

Phone

+1 858 465-6511

Employees

126

Web

https://www.erasca.com